262 related articles for article (PubMed ID: 22547910)
1. Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis.
Baroni G; Schuinski A; de Moraes TP; Meyer F; Pecoits-Filho R
Mediators Inflamm; 2012; 2012():912595. PubMed ID: 22547910
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal Membrane Preservation.
Bajo MA; Del Peso G; Teitelbaum I
Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
[TBL] [Abstract][Full Text] [Related]
3. Mediators of inflammation and fibrosis.
Lai KN; Tang SC; Leung JC
Perit Dial Int; 2007 Jun; 27 Suppl 2():S65-71. PubMed ID: 17556333
[TBL] [Abstract][Full Text] [Related]
4. Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations.
Vrtovsnik F; Coester AM; Lopes-Barreto D; de Waart DR; Van der Wal AC; Struijk DG; Krediet RT; Zweers MM
Perit Dial Int; 2010; 30(5):558-69. PubMed ID: 20421431
[TBL] [Abstract][Full Text] [Related]
5. Normal peritoneum after nine years of peritoneal dialysis with biocompatible dialysate: a case report.
Kamijo Y; Iida H; Saito K; Furutera R; Ishibashi Y
Perit Dial Int; 2013; 33(6):712-4. PubMed ID: 24335133
[No Abstract] [Full Text] [Related]
6. [Peritoneum as a dialysis membrane. II. Pathology].
Grzybowski A; Breborowicz A
Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636
[TBL] [Abstract][Full Text] [Related]
7. Long-term peritoneal membrane changes.
Coles GA; Topley N
Adv Ren Replace Ther; 2000 Oct; 7(4):289-301. PubMed ID: 11073561
[TBL] [Abstract][Full Text] [Related]
8. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
Mortier S; De Vriese AS; Lameire N
Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
[TBL] [Abstract][Full Text] [Related]
9. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
Higuchi C; Nishimura H; Sanaka T
Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions.
Williams JD; Craig KJ; Topley N; Williams GT
Kidney Int Suppl; 2003 May; (84):S158-61. PubMed ID: 12694335
[TBL] [Abstract][Full Text] [Related]
12. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
Schaefer B; Bartosova M; Macher-Goeppinger S; Sallay P; Vörös P; Ranchin B; Vondrak K; Ariceta G; Zaloszyc A; Bayazit AK; Querfeld U; Cerkauskiene R; Testa S; Taylan C; VandeWalle J; Yap Y; Krmar RT; Büscher R; Mühlig AK; Drozdz D; Caliskan S; Lasitschka F; Fathallah-Shaykh S; Verrina E; Klaus G; Arbeiter K; Bhayadia R; Melk A; Romero P; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
Kidney Int; 2018 Aug; 94(2):419-429. PubMed ID: 29776755
[TBL] [Abstract][Full Text] [Related]
13. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.
Li Q; Zheng M; Liu Y; Sun W; Shi J; Ni J; Wang Q
Mol Immunol; 2018 Feb; 94():131-139. PubMed ID: 29306153
[TBL] [Abstract][Full Text] [Related]
14. Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis.
Masola V; Bonomini M; Borrelli S; Di Liberato L; Vecchi L; Onisto M; Gambaro G; Palumbo R; Arduini A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563220
[TBL] [Abstract][Full Text] [Related]
15. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
Sikaneta T; Wu G; Abdolell M; Ng A; Mahdavi S; Svendrovski A; Tu T; Mercer T; Tong M; Oreopoulos D; Tam P
Perit Dial Int; 2016 9-10; 36(5):526-32. PubMed ID: 27282852
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.
Yung S; Chan TM
Mediators Inflamm; 2012; 2012():484167. PubMed ID: 22577250
[TBL] [Abstract][Full Text] [Related]
18. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.
Pletinck A; Vanholder R; Veys N; Van Biesen W
Nat Rev Nephrol; 2012 Sep; 8(9):542-50. PubMed ID: 22777203
[TBL] [Abstract][Full Text] [Related]
19. Encapsulating Peritoneal Sclerosis.
Alston H; Fan S; Nakayama M
Semin Nephrol; 2017 Jan; 37(1):93-102. PubMed ID: 28153198
[TBL] [Abstract][Full Text] [Related]
20. New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.
Vlahu CA; Aten J; de Graaff M; van Veen H; Everts V; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2016 11-12; 36(6):614-622. PubMed ID: 27147290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
